Quick Answer
Vivos Therapeutics, Inc. reported Long-Term Debt of $423.0 thousand for fiscal year 2020.
Vivos Therapeutics, Inc. Long-Term Debt — Annual History
| Fiscal Year | Long-Term Debt | YoY Change |
|---|---|---|
| 2020 | $423.0K | — |
Quarterly Long-Term Debt
| Quarter Ending | Long-Term Debt | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $8.38M | — | +8.0% |
| June 30, 2025 | $7.76M | — | +7227.3% |
| March 31, 2021 | $105.9K | — | -75.0% |
| December 31, 2020 | $423.1K | — | — |
- The most recent figure is from Vivos Therapeutics, Inc.’s fiscal year 2021 report (Form 10-K), filed with the SEC on March 31, 2022.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: